{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:35Z","timestamp":1792112255479,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T00:00:00Z","timestamp":1181952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T00:00:00Z","timestamp":1181952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00213-007-0840-x","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T13:24:02Z","timestamp":1182000242000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Efficacy and safety of atomoxetine for attention-deficit\/hyperactivity disorder in children and adolescents\u2014meta-analysis and meta-regression analysis"],"prefix":"10.1007","volume":"194","author":[{"given":"Jackie Y. W.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Y. L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. N.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil M. L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,16]]},"reference":[{"key":"840_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/00004583-200111000-00008","volume":"40","author":"CL Bagwell","year":"2001","unstructured":"Bagwell CL, Molina BS, Pelham WE et al (2001) Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 40:1285\u20131292","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"840_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00787-006-0549-0","volume":"15","author":"T Banaschewski","year":"2006","unstructured":"Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476\u2013495","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"840_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.148.5.564","volume":"148","author":"J Biederman","year":"1991","unstructured":"Biederman J, Newcorn J, Sprich S (1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564\u2013577","journal-title":"Am J Psychiatry"},{"key":"840_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004583-199301000-00028","volume":"32","author":"J Biederman","year":"1993","unstructured":"Biederman J, Baldessarini RJ, Wright V et al (1993) A double blind placebo controlled study of desipramine in the treatment of ADD, III: lack of impact of comorbidity and family history factors on clinical response. J Am Acad Child Adolesc Psychiatry 32:199\u2013204","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"840_CR5","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1542\/peds.110.6.e75","volume":"110","author":"J Biederman","year":"2002","unstructured":"Biederman J, Heiligenstein JH, Faries DE, Galil N, Dittmann R, Emslie GJ, Kratochvil CJ, Laws HF, Schuh KJ (2002) Atomoxetine ADHD study group. Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit\/hyperactivity disorder. Pediatrics 110(6):e75","journal-title":"Pediatrics"},{"issue":"2","key":"840_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clinthera.2006.02.008","volume":"28","author":"J Biederman","year":"2006","unstructured":"Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA (2006) A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit\/hyperactivity disorder. Clin Ther 28(2):280\u2013293","journal-title":"Clin Ther"},{"issue":"1","key":"840_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00213-006-0565-2","volume":"190","author":"J Biederman","year":"2007","unstructured":"Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM (2007) Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology 190(1):31\u201341","journal-title":"Psychopharmacology"},{"issue":"5","key":"840_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.biopsych.2006.03.066","volume":"61","author":"JK Buitelaar","year":"2006","unstructured":"Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J (2006) A randomized, double-blind study of continuation treatment for attention-deficit\/hyperactivity disorder after 1\u00a0year. Biol Psychiatry 61(5):694\u2013699","journal-title":"Biol Psychiatry"},{"issue":"5","key":"840_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology 27(5):699\u2013711","journal-title":"Neuropsychopharmacology"},{"key":"840_CR10","volume-title":"Conners\u2019 rating scales: revised technical manual","author":"CK Conners","year":"1997","unstructured":"Conners CK (1997) Conners\u2019 rating scales: revised technical manual. Multi-Health Systems, North Towanda, New York"},{"issue":"4","key":"840_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/00004583-199904000-00012","volume":"38","author":"IR Diamond","year":"1999","unstructured":"Diamond IR, Tannock R, Schachar RJ (1999) Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry 38(4):402\u2013409","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR12","volume-title":"ADHD rating scale-IV: checklists, norms, and cinical interpretations","author":"GJ DuPaul","year":"1998","unstructured":"DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD rating scale-IV: checklists, norms, and cinical interpretations. Guilford, New York"},{"key":"840_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/108705470100400404","volume":"4","author":"SV Faraone","year":"2001","unstructured":"Faraone SV, Biederman J, Monuteaux MC et al (2001) A psychometric measure of learning disability predicts educational failure four years later in boys with attention-deficit\/hyperactivity disorder. J Atten Disord 4:220\u2013230","journal-title":"J Atten Disord"},{"key":"840_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cap.1993.3.1","volume":"3","author":"GD Gammon","year":"1993","unstructured":"Gammon GD, Brown TE (1993) Fluoxetine and methylphenidate in combination for treatment of attention deficit and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3:1\u201310","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"840_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1097\/00004583-199708000-00011","volume":"36","author":"M Gaub","year":"1997","unstructured":"Gaub M, Carlson CL (1997) Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 36:1036\u20131045","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR16","first-page":"867","volume":"7","author":"J Geddes","year":"2002","unstructured":"Geddes J, Butler R (2002) Depressive disorders. Clin Evid 7:867\u2013882","journal-title":"Clin Evid"},{"key":"840_CR17","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jama.279.14.1100","volume":"279","author":"LS Goldman","year":"1998","unstructured":"Goldman LS, Genel M, Bezman RJ, Slanetz PJ (1998) Diagnosis and treatment of attention-deficit\/hyperactivity disorder in children and adolescents. JAMA 279:1100\u20131107","journal-title":"JAMA"},{"key":"840_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/00004583-200106000-00016","volume":"40","author":"RW Greene","year":"2001","unstructured":"Greene RW, Biederman J, Faraone SV et al (2001) Social impairment in girls with ADHD: patterns, gender comparisons, and correlates. J Am Acad Child Adolesc Psychiatry 40:704\u2013710","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR19","volume-title":"ECDEU assessment manual for psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Washington, DC"},{"issue":"2","key":"840_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00787-006-0506-y","volume":"15","author":"P Hazell","year":"2006","unstructured":"Hazell P, Zhang S, Wolanczyk T, Barton J, Johnson M, Zuddas A, Danckaerts M, Ladikos A, Benn D, Yoran-Hegesh R, Zeiner P, Michelson D (2006) Comorbid oppositional defiant disorder and the risk of relapse during 9\u00a0months of atomoxetine treatment for attention-deficit\/hyperactivity disorder. Eur Child Adolesc Psychiatry 15(2):105\u2013110","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"840_CR21","unstructured":"Heiligenstein J, Wagner K, Casat C et al (2001) Efficacy of atomoxetine vs placebo in school-aged children of the inattentive type. Presented at the 154th annual meeting of the American Psychiatric Association, New Orleans, LA, November 5\u201310"},{"key":"840_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","volume":"40","author":"PS Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147\u2013158","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1023\/A:1017592030434","volume":"4","author":"C Johnston","year":"2001","unstructured":"Johnston C, Mash EJ (2001) Families of children with attention-deficit\/hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev 4:183\u2013207","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"2","key":"840_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/108705470400800202","volume":"8","author":"S Kaplan","year":"2004","unstructured":"Kaplan S, Heiligenstein J, West S, Busner J, Harder D, Dittmann R, Casat C, Wernicke JF (2004) Efficacy and safety of atomoxetine in childhood attention-deficit\/hyperactivity disorder with comorbid oppositional defiant disorder. J Atten Disord 8(2):45\u201352","journal-title":"J Atten Disord"},{"issue":"1","key":"840_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","volume":"114","author":"DK Kelsey","year":"2004","unstructured":"Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ (2004) Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 114(1):e1\u20138","journal-title":"Pediatrics"},{"issue":"5","key":"840_CR26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF02849870","volume":"22","author":"JE Kemner","year":"2005","unstructured":"Kemner JE, Starr HL, Ciccone PE, Hooper-Wood CG, Crockett RS (2005) Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther 22(5):498\u2013512","journal-title":"Adv Ther"},{"issue":"2","key":"840_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/104454601750284072","volume":"11","author":"CJ Kratochvil","year":"2001","unstructured":"Kratochvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ (2001) An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11(2):167\u2013170","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"840_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/01.chi.0000169012.81536.38","volume":"44","author":"CJ Kratochvil","year":"2005","unstructured":"Kratochvil CJ, Newcorn JH, Arnold LE, Duesenberg D, Emslie GJ, Quintana H, Sarkis EH, Wagner KD, Gao H, Michelson D, Biederman J (2005) Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry 44(9):915\u2013924","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"840_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","volume":"45","author":"CJ Kratochvil","year":"2006","unstructured":"Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD, Gelowitz DL (2006) Effects of long-term atomoxetine treatment for young children with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45(8):919\u2013927","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR30","volume-title":"The CHQ user\u2019s manual","author":"JM Landgraf","year":"1996","unstructured":"Landgraf JM, Abetz L, Ware JE (1996) The CHQ user\u2019s manual, 1st edn. The Health Institute, New England Medical Center, Boston","edition":"1"},{"key":"840_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","volume":"35","author":"S Leucht","year":"1999","unstructured":"Leucht S, Pitschel-Walz G, Abraham D, Kissling W (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res 35:51\u201368","journal-title":"Schizophr Res"},{"issue":"6","key":"840_CR32","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpeds.2006.01.035","volume":"148","author":"JR Lim","year":"2006","unstructured":"Lim JR, Faught PR, Chalasani NP, Molleston JP (2006) Severe liver injury after initiating therapy with atomoxetine in two children. J Pediatr 148(6):831\u2013834","journal-title":"J Pediatr"},{"key":"840_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/cap.1992.2.115","volume":"2","author":"RL Livingstone","year":"1990","unstructured":"Livingstone RL, Dykman RA, Ackerman PT (1990) Psychiatric comorbidity and response to two doses of methylphenidate in children with attention deficit disorder. J Child Adolesc Psychopharmacol 2:115\u2013122","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"840_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1207\/S15374424jccp2901_4","volume":"29","author":"JW Maedgen","year":"2000","unstructured":"Maedgen JW, Carlson CL (2000) Social functioning and emotional regulation in the attention-deficit hyperactivity disorder subtypes. J Clin Child Psychol 29:30\u201342","journal-title":"J Clin Child Psychol"},{"issue":"5","key":"840_CR35","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T (2001) Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose\u2013response study. Pediatrics 108(5):E83","journal-title":"Pediatrics"},{"issue":"11","key":"840_CR36","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","volume":"159","author":"D Michelson","year":"2002","unstructured":"Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D (2002) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159(11):1896\u20131901","journal-title":"Am J Psychiatry"},{"key":"840_CR37","first-page":"2):112","volume":"3","author":"D Michelson","year":"2003","unstructured":"Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D (2003) Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53(2):112\u2013120","journal-title":"Biol Psychiatry"},{"issue":"7","key":"840_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/01.chi.0000125089.35109.81","volume":"43","author":"D Michelson","year":"2004","unstructured":"Michelson D, Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J (2004) Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 43(7):896\u2013904","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"840_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00004583-200503000-00008","volume":"44","author":"JH Newcorn","year":"2005","unstructured":"Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D (2005) Atomoxetine treatment in children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44(3):240\u2013248","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR40","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/00004583-199309000-00028","volume":"32","author":"CS Pataki","year":"1993","unstructured":"Pataki CS, Carlson GA, Kelly KL et al (1993) Side effects of methylphenidate and desipramine alone and in combination in children. J Am Acad Child Adolesc Psychiatry 32:1065\u20131072","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR41","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV (1998) What\u2019s wrong with Bonferroni adjustments. BMJ 316:1236\u20131238","journal-title":"BMJ"},{"issue":"4","key":"840_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00004703-200408000-00006","volume":"25","author":"AR Perwien","year":"2004","unstructured":"Perwien AR, Faries DE, Kratochvil CJ, Sumner CR, Kelsey DK, Allen AJ (2004) Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine. J Dev Behav Pediatr 25(4):264\u2013271","journal-title":"J Dev Behav Pediatr"},{"key":"840_CR43","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/00004583-198911000-00012","volume":"28","author":"SR Pliszka","year":"1989","unstructured":"Pliszka SR (1989) Effect of anxiety on cognition, behavior and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882\u2013887","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 7","key":"840_CR44","first-page":"50","volume":"59","author":"SR Pliszka","year":"1998","unstructured":"Pliszka SR (1998) Comorbidity of attention-deficit\/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 59(Suppl 7):50\u201358","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"840_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10578-006-0032-7","volume":"37","author":"H Quintana","year":"2007","unstructured":"Quintana H, Butterbaugh GJ, Purnell W, Layman AK (2007) Fluoxetine monotherapy in attention-deficit\/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents. Child Psychiatry Hum Dev 37(3):241\u2013253","journal-title":"Child Psychiatry Hum Dev"},{"key":"840_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00004583-199303000-00014","volume":"32","author":"MD Rapport","year":"1993","unstructured":"Rapport MD, Carlson GA, Kelly KL et al (1993) Methylphenidate and desipramine in hospitalized children, I: separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 32:333\u2013342","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR47","first-page":"896","volume":"7","author":"GM Soomro","year":"2002","unstructured":"Soomro GM (2002) Obsessive\u2013compulsive disorder. Clin Evid 7:896\u2013905","journal-title":"Clin Evid"},{"issue":"5","key":"840_CR48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1176\/ajp.155.5.693","volume":"155","author":"T Spencer","year":"1998","unstructured":"Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155(5):693\u2013695","journal-title":"Am J Psychiatry"},{"issue":"3","key":"840_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/10445460152595577","volume":"11","author":"T Spencer","year":"2001","unstructured":"Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J, Faraone SV, Rea J, Witcher J, Zervas S (2001) An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11(3):251\u2013265","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"840_CR50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4088\/JCP.v63n1209","volume":"63","author":"T Spencer","year":"2002","unstructured":"Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ (2002) Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit\/hyperactivity disorder. J Clin Psychiatry 63(12):1140\u20131147","journal-title":"J Clin Psychiatry"},{"issue":"10 Suppl","key":"840_CR51","first-page":"11S","volume":"97","author":"HL Starr","year":"2005","unstructured":"Starr HL, Kemner J (2005) Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. J Natl Med Assoc 97(10 Suppl):11S\u201316S","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"840_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15563650600795644","volume":"45","author":"SD Stojanovski","year":"2007","unstructured":"Stojanovski SD, Casavant MJ, Mousa HM, Baker P, Nahata MC (2007) Atomoxetine-induced hepatitis in a child. Clin Toxicol 45(1):51\u201355","journal-title":"Clin Toxicol"},{"key":"840_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0009-9236(99)70038-X","volume":"66","author":"J Swanson","year":"1999","unstructured":"Swanson J, Gupta S, Guinta D et al (1999) Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 66:295\u2013305","journal-title":"Clin Pharmacol Ther"},{"key":"840_CR54","unstructured":"Tannock R, Schachar R (1992) Is ADHD with comorbid overanxious disorder different from ADHD? In: Comorbidity of ADHD: discriminating features and methodologic problems, Newcorn J (chair). Symposium conducted at the 39th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC"},{"key":"840_CR55","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00004583-199507000-00012","volume":"34","author":"R Tannock","year":"1995","unstructured":"Tannock R, Ickowicz A, Schachar R (1995) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34:886\u2013896","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"840_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1017\/S0033291700013039","volume":"17","author":"E Taylor","year":"1987","unstructured":"Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M (1987) Which boys respond to stimulant medication? A controlled trial of MPH in boys with disruptive behavior. Psychol Med 17:121\u2013143","journal-title":"Psychol Med"},{"issue":"12","key":"840_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","volume":"56","author":"The MTA Cooperative Group","year":"1999","unstructured":"The MTA Cooperative Group (1999) Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 56(12):1088\u20131096","journal-title":"Arch Gen Psychiatry"},{"key":"840_CR58","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/00004583-200207000-00014","volume":"41","author":"RD Todd","year":"2002","unstructured":"Todd RD, Sitdhiraksa N, Reich W et al (2002) Discrimination of DSM-IV and latent class attention-deficit\/hyperactivity disorder subtypes by educational and cognitive performance in a population-based sample of child and adolescent twins. J Am Acad Child Adolesc Psychiatry 41:820\u2013828","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"840_CR59","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","volume":"44","author":"M Weiss","year":"2005","unstructured":"Weiss M, Tannock R, Kratochvil C, Dunn D, Velez-Borras J, Thomason C, Tamura R, Kelsey D, Stevens L, Allen AJ (2005) A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44(7):647\u2013655","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"840_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpeds.2006.01.052","volume":"149","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK, Feldman PD, Levine LR (2006) Long-term atomoxetine treatment in adolescents with attention-deficit\/hyperactivity disorder. J Pediatr 149(1):112\u2013119","journal-title":"J Pediatr"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-007-0840-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0840-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T12:07:08Z","timestamp":1652616428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-007-0840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,16]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0840-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,16]]},"assertion":[{"value":"31 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}